Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis

Area of Science:

• Nephrology
• Immunology
• Cell Biology

Background:

• Conflicting reports exist on interleukin-10 (IL-10) effects on mesangial cells, with both proliferative/antiproliferative and pro/anti-inflammatory actions documented.
• The impact of IL-10 on glomerulonephritis characterized by mesangial proliferation remains unclear.

Purpose of the Study:

• To investigate the potential of IL-10 to limit experimental mesangial proliferative glomerulonephritis.
• To test the hypothesis that IL-10 administration would reduce mesangial cell proliferation in an animal model.

Main Methods:

• Mesangial proliferative glomerulonephritis was induced in rats using anti-Thy 1 antibody.
• IL-10 was administered to experimental rats, and outcomes were compared to control groups.
• Glomerular proliferation was assessed by PCNA and bromodeoxyuridine staining; inflammatory cell influx and gene expression (IL-1beta, ICAM-1, MCP-1, osteopontin) were analyzed.

Main Results:

• IL-10 treatment significantly reduced glomerular cellular proliferation and the number of cells within glomeruli.
• A decrease in glomerular macrophage influx was observed in IL-10 treated rats.
• Renal IL-1beta mRNA and glomerular ICAM-1 expression were reduced, while MCP-1 and osteopontin mRNA levels were unchanged.

Conclusions:

• IL-10 effectively diminishes inflammatory cell recruitment and mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
• The anti-proliferative effects of IL-10 on mesangial cells may involve direct actions and macrophage-mediated pathways.
• IL-10 demonstrates potential as a therapeutic agent for glomerulonephritis involving mesangial proliferation.